-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
REGENEREX PHARMA, INC. quarterly and annual Depreciation history and change rate from 2017 to Q2 2025.
- REGENEREX PHARMA, INC. Depreciation for the quarter ending 30 Jun 2025 was $1,259, a 10.1% increase year-over-year.
- REGENEREX PHARMA, INC. annual Depreciation for 2024 was $3,054, a 28.6% decline from 2023.
- REGENEREX PHARMA, INC. annual Depreciation for 2023 was $4,278, a 25.1% increase from 2022.
- REGENEREX PHARMA, INC. annual Depreciation for 2022 was $3,420, a 3.09% decline from 2021.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)